A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy

BACKGROUND: Many men develop a rising PSA after initial therapy for prostate cancer. While some of these men will develop a local or metastatic recurrence that warrants further therapy, others will have no evidence of disease progression. We hypothesized that an expression biomarker panel can predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Tohru, Kollmeyer, Thomas M., Morlan, Bruce W., Anderson, S. Keith, Bergstralh, Eric J., Davis, Brian J., Asmann, Yan W., Klee, George G., Ballman, Karla V., Jenkins, Robert B.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565588/
https://www.ncbi.nlm.nih.gov/pubmed/18846227
http://dx.doi.org/10.1371/journal.pone.0002318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565588/
https://www.ncbi.nlm.nih.gov/pubmed/18846227
http://dx.doi.org/10.1371/journal.pone.0002318

Ejemplares similares